1. Home
  2. News
  3. Sudarshan Pharma Industries Ltd
  4. Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
More Sudarshan Pharma Industries Ltd news
Sudarshan Pharma Industries LtdBSE: SUDARSHAN

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Jul 7, 2026 at 1:54 AM EDT · Issued by Sudarshan Pharma Industries Ltd via BSE India

Filed with BSE · Jul 7, 2026 at 1:54 AM EDT · 3 pages · English

On 6ix: 6ix.com/news/compliances-certificate-under-reg-74-5-of-sebi-dp-regulations-2018-3480

Sudarshan Pharma Industries Ltd on 6ix

Earlier from Sudarshan Pharma Industries

  • Sudarshan Pharma Industries Ltd Press Release Jun 25 2026Jun 25
  • Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJun 25
  • Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJun 25
  • Sudarshan Pharma Industries Ltd Press Release Jun 18 2026Jun 18
  • Board Meeting Outcome for Board Meeting Scheduled On Thursday, 18 June 2026 CancelledJun 18

Later from Sudarshan Pharma Industries

  • Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.Jul 14
  • Sudarshan Pharma Industries Ltd Press Release Jul 14 2026Jul 14
  • Board Meeting Intimation for To Consider And Approve Financial Results For The Quarter Ended 30/June/2026Aug 9
  • Sudarshan Pharma Industries Ltd Press Release Aug 09 2026Aug 9
  • Sudarshan Pharma Industries Ltd Press Release Aug 10 2026Aug 10
All Sudarshan Pharma Industries news releases↗

Follow Sudarshan Pharma Industries into a list and get an email when it puts out news.

Follow Sudarshan Pharma Industries
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer